Skip common site navigation and headers
United States Environmental Protection Agency
Endocrine Disruptor Research Initiative
Contact Us | Print Version Search: NCER Advanced Search
Begin Hierarchical Links EPA Home > Table2.NCI >  58088-04 Perinatal Hormonal Factors & Rat Prostate Carcinogenesis End Hierarchical Links End Hierarchical Links

 

EDRI Federal Project Inventory:
58088-04 Perinatal Hormonal Factors & Rat Prostate Carcinogenesis



  1. Sponsor Organization: NIH/NCI

  2. Project Title: 58088-04 PERINATAL HORMONAL FACTORS & RAT PROSTATE CARCINOGENESIS

  3. Project Focus: HUMAN HEALTH EFFECTS, EXPOSURE ASSESSMENT

  4. Description: Male human populations that are at high risk for prostate cancer often have higher circulating testosterone levels thatpopulations that are at lower risk for this disease. Circulating testosterone levels are particularly high in pregnantwomen of high risk populations compared with lower risk populations. Perinatal administration of considerable doses ofdiethylstilbestrol (DES) to male mice causes carcinomas and preneoplasia of the accessory sex glands, including theprostate. These data suggest that prenatal exposure to DES and androgens increases risk for prostate cancerdevelopment later in life. This proposal seeks to test this hypothesis. We will expose male rats in utero and/orneonatally to testosterone or DES at doses that are not teratogenic or toxic, as to be determined in preliminary studies. Subsequently, we will expose these rats to treatments that have been shown to induce prostate cancer in rats that werenot exposed to exogenous hormones perinatally. We will then compare the incidence, multiplicity and latency ofprostate carcinomas in the perinatally hormone exposed rats with these parameters in rats that were not exposedprenatally. We will use three models of prostate cancer induction that differ in their mechanism of action: (1) chronictestosterone administration, (2) a single injection with N- methyl-N-nitrosourea followed by chronic testosteroneadministration, and (3) chronic administration of estradiol-17beta and testosterone. In addition, we will determine the effects of perinatal androgen and DES exposure on circulating testosterone and on androgen and estrogen sensitivity ofthe male accessory sex glands, including the prostate.

  5. References:

  6. Category: MODELS

  7. Subcategory: BASIC RESEARCH

  8. Keywords for Experimental System/Species: LABORATORY STUDY, IN UTERO

  9. Keywords for Experimental Endpoints: MALE, CARCINOGENESIS, REPRODUCTIVE

  10. Chemical Agents: DIETHYLSTILBESTROL (DES), ANDROGENS, TESTOSTERONE, N-METHYL- N- NITROSOUREA, ESTRADIOL-17BETA

  11. Performing Institution: NEW YORK UNIVERSITY

  12. Contact: CONTACT PERSON:ELAINE C. LEE; BUILDING 31; 11A21, NATIONAL CANCER INSTITUTE, NIH,BETHESDA, MD 20892-2590; 301 496-5515; LEEE@0D.NCI.NIH.GOV


 

 
Begin Site Footer